Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Exosomes Infected with Prions Diagnostic for vCJD

By LabMedica International staff writers
Posted on 24 Oct 2012
Newly available genetic sequencing enables scientists to discover cells infected with prions, the infectious agent responsible Creutzfeldt-Jakob disease (vCJD) and Bovine Spongiform Encephalopathy (BSE), commonly known as Mad Cow Disease.

Exosomes are shed into blood, urine, and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. More...
If the exosomes are infected with prions, they also carry a specific signature of microRNA's (miRNAs). In this study, scientists focused their genetic testing on the exosomes. Circulating exosomes released during prion infection have a distinct miRNA signature that can be utilized for diagnosis and understanding pathogenic mechanisms in prion disease. Associate Professor Andrew Hill - from the Department of Biochemistry and Molecular Biology at the Bio21 Institute (Melbourne, VIC, Australia), said that these particles travel in the bloodstream, making a diagnostic blood test a possibility.

Mad Cow disease was linked to the deaths of nearly 200 people in Great Britain who consumed meat from infected animals in the late 1980s. Since the year 2000, the Australian Red Cross Blood Service has not accepted blood from anybody who lived in the UK for more than six months between 1980 and 1996, or who received a blood transfusion in the UK after 1980.

Commenting on the possibility in the future of a blood test for Mad Cow Disease, Prof. Hill said, "This might provide a way to screen people who have spent time in the UK, who currently face restrictions on their ability to donate blood. With a simple blood test nurses could deem a prospective donor's blood as healthy, with the potential to significantly boost critical blood stocks."

The research is published in the September 2012 issue of Oxford University Press Nucleic Acids Research. Lead author Dr. Shayne Bellingham said the breakthrough might also help detect other human neurodegenerative diseases, such as Alzheimer's and Parkinson's.

The study was undertaken at the University of Melbourne (VIC, Australia), with assistance from the Mental Health Research Institute of Victoria, the National Health and Medical Research Council and the Australian Research Council.

Related Links:
Bio21 Institute
University of Melbourne


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test utilizes mtDNA biomarkers to detect molecular signatures associated with endometriosis (Photo courtesy of Shutterstock)

Endometriosis Blood Test Could Replace Invasive Laparoscopic Diagnosis

Endometriosis affects an estimated 1 in 10 women globally, yet diagnosis can take 7 to 10 years on average due to the invasive nature of laparoscopy and lack of accurate, non-invasive tests.... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.